Search filters

List of works by Eri T Kato

Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions

scientific article published on 07 January 2020

Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

scientific article published on 01 April 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 10 November 2018

Declare-Timi 58: Participants' Baseline Characteristics

scientific article published on 11 January 2018

Direct comparison of optical coherence tomography and high-definition 60-MHz intravascular ultrasound imaging of intra-procedural stent thrombosis in a patient with acute coronary syndrome

scientific article published on 07 December 2018

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

scientific article published on 18 March 2019

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial

scientific article published on 10 June 2019

Overview of Oral Antithrombotic Treatment in Elderly Patients with Atrial Fibrillation

article

Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"

scientific article published on 28 October 2019

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

scientific article published in The Lancet

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

scientific article published on 07 February 2018

Paulina is supported by:

About Paulina

Help